MENU
HLTRF
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

HLS Therapeutics (HLTRF) Ownership - Who owns HLS Therapeutics?

Profile

Industry
N/A
Address
10 Carlson Court
Phone
+1 647 495-9000
Employees
99
Web
https://www.hlstherapeutics.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
153.75M
P/E Ratio
N/A
Total Cash
21.21M
Projected Growth
N/A
Total Debt
95.2M
Revenue
61.67M
Risk (Beta)
1.24
Dividend Yield
0.03
Total Cash/Share
0.66
Total Debt/Equity
N/A
Revenue/Share
1.90 USD as % of share price

Fundamentals

HLTRF
Capitalization
154M
P/E Ratio
N/A
Risk (Beta)
1.24
Dividend Yield
0.03
Total Cash
21.2M
Total Cash/Share
0.66
Total Debt
95.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.90%
Revenue
61.7M
ROE
N/A
Book Value
119M
P/B Ratio
1.25
Cash Flow
N/A
Earnings
-0.8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
265M
Current Ratio
1.48
Current Revenue Per Employee
153718.75
Dividends Per Share - Security
0.04
EBITDA
15.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.21
Revenue To Assets
-10.21
Shares Held By Institutions
13.3M
Shares Outstanding - Current
32.4M
Total Liabilities
115M
Total Volume MTD
N/A
Value
1
Gain YTD
-26.042
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
10 Carlson Court
Phone
+1 647 495-9000
Employees
99
Web
https://www.hlstherapeutics.com